Presenters shared their personal highlights of attending ASCO GI 2026. The 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium showcased not only transformative ...

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that new data from the ...

Pasithea Therapeutics Corp. has announced the acceptance of an abstract for a poster presentation at the upcoming American Society for Clinical Oncology (ASCO) Annual Meeting, scheduled for May 30 to ...

The clinical trial tech companies Medidata and Medable are both taking to the floor of the American Society of Clinical Oncology meeting in Chicago to spread the word about new offerings. Medidata’s ...

Bicara Therapeutics Inc. announced that new data from their ongoing Phase 1/1b clinical trial of ficerafusp alfa, a first-in-class bifunctional antibody, will be presented orally at the 2025 ASCO ...

Despite being more likely to be diagnosed with triple negative breast cancer (TNBC), Black women remain underrepresented in clinical trials across the U.S. While distance from trial sites may not be a ...

Updated interim results with an additional ~13 weeks of follow-up since the prior update[212Pb]VMT-α-NET continues to be well-tolerated Updated ...

Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials ASCO Guidelines provide recommendations with comprehensive ...

When considering a sequence of therapy for a patient with metastatic breast cancer, oncologists rely heavily on clinical trial data. Sometimes, however, clinical trial data may not be as reliable as ...